COVID-19 Australia Information Centre

Novartis Australia responds to pandemic challenges faced by patient organisations

Patient in wheelchair
Novartis is responding to the challenges faced by patient organisations with the announcement of three key initiatives to help them continue their critical work throughout the COVID-19 crisis. 

More information
Novartis to assist Australian Government with initial supply of hydroxychloroquine

SARS-CoV-2 is the virus that causes COVID-19
Novartis Australia, and its generics and biosimilars division Sandoz, has confirmed that it will be working with the Australian government to provide an initial supply of generic hydroxychloroquine to support the COVID-19 pandemic response.

More information
Coronavirus (COVID-19) Novartis Australia & New Zealand

Illustration: Coronavirus (Centers for Disease Control and Prevention)
Novartis in Australia and New Zealand continues to closely monitor and respond to the coronavirus (COVID-19) situation. Our priority is to ensure the health and safety of our people, patients, and healthcare professionals.

 

More information
Novartis working from home

Related Links